nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—Vismodegib—skin cancer	0.377	0.466	CbGbCtD
Sodium lauryl sulfate—ALB—Vemurafenib—skin cancer	0.298	0.368	CbGbCtD
Sodium lauryl sulfate—ALB—Fluorouracil—skin cancer	0.134	0.166	CbGbCtD
Sodium lauryl sulfate—Dehydration—Vismodegib—skin cancer	0.00274	0.0143	CcSEcCtD
Sodium lauryl sulfate—Feeling hot—Imiquimod—skin cancer	0.00272	0.0142	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Vismodegib—skin cancer	0.00268	0.014	CcSEcCtD
Sodium lauryl sulfate—Tingling sensation—Imiquimod—skin cancer	0.00266	0.0139	CcSEcCtD
Sodium lauryl sulfate—Tenderness—Imiquimod—skin cancer	0.00245	0.0128	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Imiquimod—skin cancer	0.00226	0.0118	CcSEcCtD
Sodium lauryl sulfate—Coagulopathy—Dactinomycin—skin cancer	0.00182	0.00952	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Dactinomycin—skin cancer	0.0018	0.00944	CcSEcCtD
Sodium lauryl sulfate—Swelling—Imiquimod—skin cancer	0.00176	0.0092	CcSEcCtD
Sodium lauryl sulfate—Tenderness—Bleomycin—skin cancer	0.00174	0.0091	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Bleomycin—skin cancer	0.00174	0.0091	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Vismodegib—skin cancer	0.00174	0.00908	CcSEcCtD
Sodium lauryl sulfate—Coagulopathy—Temozolomide—skin cancer	0.00165	0.00861	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Dactinomycin—skin cancer	0.00162	0.00849	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Bleomycin—skin cancer	0.00161	0.0084	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Imiquimod—skin cancer	0.00158	0.00828	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Dactinomycin—skin cancer	0.00155	0.00809	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Fluorouracil—skin cancer	0.0015	0.00787	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Dactinomycin—skin cancer	0.0015	0.00783	CcSEcCtD
Sodium lauryl sulfate—Irritability—Imiquimod—skin cancer	0.00148	0.00775	CcSEcCtD
Sodium lauryl sulfate—Tingling sensation—Fluorouracil—skin cancer	0.00147	0.00768	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Fluorouracil—skin cancer	0.00135	0.00708	CcSEcCtD
Sodium lauryl sulfate—Tenderness—Fluorouracil—skin cancer	0.00135	0.00708	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Imiquimod—skin cancer	0.00131	0.00683	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Fluorouracil—skin cancer	0.0013	0.00679	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Imiquimod—skin cancer	0.00129	0.00675	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Bleomycin—skin cancer	0.00128	0.00669	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Vismodegib—skin cancer	0.00126	0.00658	CcSEcCtD
Sodium lauryl sulfate—Intestinal obstruction—Docetaxel—skin cancer	0.00125	0.00654	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Vismodegib—skin cancer	0.00125	0.00653	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Fluorouracil—skin cancer	0.00125	0.00653	CcSEcCtD
Sodium lauryl sulfate—Constipation—Vismodegib—skin cancer	0.00124	0.00647	CcSEcCtD
Sodium lauryl sulfate—Disorientation—Bleomycin—skin cancer	0.00123	0.00645	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Dactinomycin—skin cancer	0.00123	0.00643	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Dactinomycin—skin cancer	0.00119	0.00624	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Vismodegib—skin cancer	0.00118	0.00619	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Imiquimod—skin cancer	0.00118	0.00617	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Imiquimod—skin cancer	0.00117	0.00613	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Vismodegib—skin cancer	0.00114	0.00599	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Bleomycin—skin cancer	0.00113	0.00588	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Docetaxel—skin cancer	0.00109	0.00568	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Vemurafenib—skin cancer	0.00107	0.00561	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Vismodegib—skin cancer	0.00104	0.00543	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Fluorouracil—skin cancer	0.00102	0.00536	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Vismodegib—skin cancer	0.00102	0.00536	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vismodegib—skin cancer	0.000991	0.00518	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Docetaxel—skin cancer	0.000977	0.00511	CcSEcCtD
Sodium lauryl sulfate—Swelling—Fluorouracil—skin cancer	0.000971	0.00508	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Imiquimod—skin cancer	0.000959	0.00502	CcSEcCtD
Sodium lauryl sulfate—Disorientation—Fluorouracil—skin cancer	0.000958	0.00501	CcSEcCtD
Sodium lauryl sulfate—Bronchospasm—Bleomycin—skin cancer	0.000937	0.0049	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Docetaxel—skin cancer	0.000925	0.00484	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vismodegib—skin cancer	0.000921	0.00481	CcSEcCtD
Sodium lauryl sulfate—Rash—Vismodegib—skin cancer	0.000913	0.00477	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vismodegib—skin cancer	0.000912	0.00477	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Vemurafenib—skin cancer	0.000895	0.00468	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Dactinomycin—skin cancer	0.000889	0.00465	CcSEcCtD
Sodium lauryl sulfate—Infection—Vemurafenib—skin cancer	0.000889	0.00465	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Temozolomide—skin cancer	0.000865	0.00452	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vismodegib—skin cancer	0.00086	0.0045	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Temozolomide—skin cancer	0.000847	0.00443	CcSEcCtD
Sodium lauryl sulfate—Syncope—Imiquimod—skin cancer	0.000838	0.00438	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Bleomycin—skin cancer	0.000838	0.00438	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Vemurafenib—skin cancer	0.000836	0.00437	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Bleomycin—skin cancer	0.000833	0.00436	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Imiquimod—skin cancer	0.000826	0.00432	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Imiquimod—skin cancer	0.000822	0.0043	CcSEcCtD
Sodium lauryl sulfate—Irritability—Fluorouracil—skin cancer	0.000818	0.00428	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Imiquimod—skin cancer	0.00081	0.00423	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Temozolomide—skin cancer	0.000809	0.00423	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Docetaxel—skin cancer	0.000809	0.00423	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Temozolomide—skin cancer	0.000804	0.0042	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Imiquimod—skin cancer	0.000796	0.00416	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Imiquimod—skin cancer	0.000793	0.00415	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Temozolomide—skin cancer	0.000783	0.00409	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Vemurafenib—skin cancer	0.000778	0.00407	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Temozolomide—skin cancer	0.000773	0.00404	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Vemurafenib—skin cancer	0.000771	0.00403	CcSEcCtD
Sodium lauryl sulfate—Constipation—Vemurafenib—skin cancer	0.000765	0.004	CcSEcCtD
Sodium lauryl sulfate—Oedema—Imiquimod—skin cancer	0.000763	0.00399	CcSEcCtD
Sodium lauryl sulfate—Lightheadedness—Docetaxel—skin cancer	0.000762	0.00399	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Bleomycin—skin cancer	0.000759	0.00397	CcSEcCtD
Sodium lauryl sulfate—Infection—Imiquimod—skin cancer	0.000758	0.00396	CcSEcCtD
Sodium lauryl sulfate—Shock—Imiquimod—skin cancer	0.000751	0.00392	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Imiquimod—skin cancer	0.000745	0.00389	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Fluorouracil—skin cancer	0.000741	0.00387	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Docetaxel—skin cancer	0.000739	0.00387	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Imiquimod—skin cancer	0.000737	0.00386	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Imiquimod—skin cancer	0.000727	0.0038	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Docetaxel—skin cancer	0.000718	0.00375	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Vemurafenib—skin cancer	0.000707	0.0037	CcSEcCtD
Sodium lauryl sulfate—Swelling—Docetaxel—skin cancer	0.000701	0.00367	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Imiquimod—skin cancer	0.000685	0.00358	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Docetaxel—skin cancer	0.000682	0.00357	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Imiquimod—skin cancer	0.00068	0.00356	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Imiquimod—skin cancer	0.000663	0.00347	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Vemurafenib—skin cancer	0.000659	0.00345	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Imiquimod—skin cancer	0.000658	0.00344	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Fluorouracil—skin cancer	0.000651	0.0034	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Docetaxel—skin cancer	0.00065	0.0034	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Fluorouracil—skin cancer	0.000647	0.00339	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Vemurafenib—skin cancer	0.000642	0.00336	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Temozolomide—skin cancer	0.00064	0.00335	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Vemurafenib—skin cancer	0.000633	0.00331	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Imiquimod—skin cancer	0.000624	0.00326	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vemurafenib—skin cancer	0.000612	0.0032	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Imiquimod—skin cancer	0.000606	0.00317	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Imiquimod—skin cancer	0.000603	0.00315	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Imiquimod—skin cancer	0.000603	0.00315	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Vemurafenib—skin cancer	0.000592	0.00309	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Fluorouracil—skin cancer	0.00059	0.00308	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Docetaxel—skin cancer	0.000575	0.00301	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vemurafenib—skin cancer	0.000569	0.00297	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Bleomycin—skin cancer	0.000565	0.00296	CcSEcCtD
Sodium lauryl sulfate—Rash—Vemurafenib—skin cancer	0.000564	0.00295	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vemurafenib—skin cancer	0.000563	0.00295	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Imiquimod—skin cancer	0.000562	0.00294	CcSEcCtD
Sodium lauryl sulfate—Headache—Vemurafenib—skin cancer	0.00056	0.00293	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Temozolomide—skin cancer	0.000549	0.00287	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Imiquimod—skin cancer	0.000547	0.00286	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Bleomycin—skin cancer	0.000542	0.00283	CcSEcCtD
Sodium lauryl sulfate—Oedema—Bleomycin—skin cancer	0.000542	0.00283	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Imiquimod—skin cancer	0.00054	0.00282	CcSEcCtD
Sodium lauryl sulfate—Infection—Bleomycin—skin cancer	0.000538	0.00282	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Docetaxel—skin cancer	0.000535	0.0028	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vemurafenib—skin cancer	0.000531	0.00278	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Fluorouracil—skin cancer	0.00053	0.00277	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Temozolomide—skin cancer	0.000528	0.00276	CcSEcCtD
Sodium lauryl sulfate—Bronchospasm—Docetaxel—skin cancer	0.000526	0.00275	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Imiquimod—skin cancer	0.000522	0.00273	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Bleomycin—skin cancer	0.000517	0.0027	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Bleomycin—skin cancer	0.000506	0.00265	CcSEcCtD
Sodium lauryl sulfate—Oedema—Dactinomycin—skin cancer	0.000505	0.00264	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Imiquimod—skin cancer	0.000504	0.00264	CcSEcCtD
Sodium lauryl sulfate—Infection—Dactinomycin—skin cancer	0.000502	0.00263	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Temozolomide—skin cancer	0.000495	0.00259	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Bleomycin—skin cancer	0.000487	0.00254	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Fluorouracil—skin cancer	0.000486	0.00254	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Temozolomide—skin cancer	0.000485	0.00254	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Imiquimod—skin cancer	0.000485	0.00254	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Bleomycin—skin cancer	0.000483	0.00253	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Dactinomycin—skin cancer	0.000482	0.00252	CcSEcCtD
Sodium lauryl sulfate—Rash—Imiquimod—skin cancer	0.000481	0.00252	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Imiquimod—skin cancer	0.000481	0.00251	CcSEcCtD
Sodium lauryl sulfate—Headache—Imiquimod—skin cancer	0.000478	0.0025	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Temozolomide—skin cancer	0.000475	0.00249	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Bleomycin—skin cancer	0.000471	0.00246	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Docetaxel—skin cancer	0.00047	0.00246	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Docetaxel—skin cancer	0.000469	0.00245	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Docetaxel—skin cancer	0.000467	0.00244	CcSEcCtD
Sodium lauryl sulfate—Oedema—Temozolomide—skin cancer	0.000457	0.00239	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Temozolomide—skin cancer	0.000457	0.00239	CcSEcCtD
Sodium lauryl sulfate—Infection—Temozolomide—skin cancer	0.000454	0.00237	CcSEcCtD
Sodium lauryl sulfate—Nausea—Imiquimod—skin cancer	0.000453	0.00237	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Fluorouracil—skin cancer	0.000447	0.00234	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Temozolomide—skin cancer	0.000442	0.00231	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Fluorouracil—skin cancer	0.000439	0.0023	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Dactinomycin—skin cancer	0.000439	0.0023	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Dactinomycin—skin cancer	0.000436	0.00228	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Temozolomide—skin cancer	0.000436	0.00228	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Bleomycin—skin cancer	0.000431	0.00225	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Bleomycin—skin cancer	0.000428	0.00224	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Docetaxel—skin cancer	0.000426	0.00223	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Fluorouracil—skin cancer	0.000421	0.0022	CcSEcCtD
Sodium lauryl sulfate—Oedema—Fluorouracil—skin cancer	0.000421	0.0022	CcSEcCtD
Sodium lauryl sulfate—Infection—Fluorouracil—skin cancer	0.000418	0.00219	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000413	0.00216	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Fluorouracil—skin cancer	0.000411	0.00215	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Temozolomide—skin cancer	0.000411	0.00215	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Temozolomide—skin cancer	0.000408	0.00213	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Fluorouracil—skin cancer	0.000402	0.0021	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Dactinomycin—skin cancer	0.0004	0.00209	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Dactinomycin—skin cancer	0.0004	0.00209	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Bleomycin—skin cancer	0.000399	0.00209	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Temozolomide—skin cancer	0.000397	0.00208	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Temozolomide—skin cancer	0.000394	0.00206	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Fluorouracil—skin cancer	0.000394	0.00206	CcSEcCtD
Sodium lauryl sulfate—Constipation—Temozolomide—skin cancer	0.000391	0.00204	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Bleomycin—skin cancer	0.000389	0.00203	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Bleomycin—skin cancer	0.000383	0.002	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Docetaxel—skin cancer	0.000382	0.002	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Fluorouracil—skin cancer	0.000378	0.00198	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Fluorouracil—skin cancer	0.000376	0.00196	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Temozolomide—skin cancer	0.000374	0.00195	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Dactinomycin—skin cancer	0.000372	0.00195	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Fluorouracil—skin cancer	0.000366	0.00191	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Docetaxel—skin cancer	0.000365	0.00191	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Temozolomide—skin cancer	0.000363	0.0019	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Dactinomycin—skin cancer	0.000363	0.0019	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Temozolomide—skin cancer	0.000361	0.00189	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Temozolomide—skin cancer	0.000361	0.00189	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Dactinomycin—skin cancer	0.000346	0.00181	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Bleomycin—skin cancer	0.000345	0.0018	CcSEcCtD
Sodium lauryl sulfate—Rash—Bleomycin—skin cancer	0.000342	0.00179	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Bleomycin—skin cancer	0.000341	0.00179	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Temozolomide—skin cancer	0.000337	0.00176	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Fluorouracil—skin cancer	0.000335	0.00175	CcSEcCtD
Sodium lauryl sulfate—Syncope—Docetaxel—skin cancer	0.000334	0.00175	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Fluorouracil—skin cancer	0.000333	0.00174	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Docetaxel—skin cancer	0.000329	0.00172	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Temozolomide—skin cancer	0.000328	0.00172	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Docetaxel—skin cancer	0.000327	0.00171	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Temozolomide—skin cancer	0.000323	0.00169	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Docetaxel—skin cancer	0.000323	0.00169	CcSEcCtD
Sodium lauryl sulfate—Nausea—Bleomycin—skin cancer	0.000322	0.00168	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Dactinomycin—skin cancer	0.000321	0.00168	CcSEcCtD
Sodium lauryl sulfate—Rash—Dactinomycin—skin cancer	0.000319	0.00167	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Docetaxel—skin cancer	0.000317	0.00166	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Temozolomide—skin cancer	0.000313	0.00164	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Fluorouracil—skin cancer	0.00031	0.00162	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Docetaxel—skin cancer	0.000304	0.00159	CcSEcCtD
Sodium lauryl sulfate—Oedema—Docetaxel—skin cancer	0.000304	0.00159	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Temozolomide—skin cancer	0.000302	0.00158	CcSEcCtD
Sodium lauryl sulfate—Infection—Docetaxel—skin cancer	0.000302	0.00158	CcSEcCtD
Sodium lauryl sulfate—Nausea—Dactinomycin—skin cancer	0.0003	0.00157	CcSEcCtD
Sodium lauryl sulfate—Shock—Docetaxel—skin cancer	0.000299	0.00156	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Fluorouracil—skin cancer	0.000298	0.00156	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Docetaxel—skin cancer	0.000297	0.00155	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Temozolomide—skin cancer	0.000291	0.00152	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Docetaxel—skin cancer	0.00029	0.00152	CcSEcCtD
Sodium lauryl sulfate—Rash—Temozolomide—skin cancer	0.000288	0.00151	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Fluorouracil—skin cancer	0.000288	0.00151	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Temozolomide—skin cancer	0.000288	0.00151	CcSEcCtD
Sodium lauryl sulfate—Headache—Temozolomide—skin cancer	0.000286	0.0015	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Docetaxel—skin cancer	0.000284	0.00149	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Fluorouracil—skin cancer	0.000279	0.00146	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Docetaxel—skin cancer	0.000273	0.00143	CcSEcCtD
Sodium lauryl sulfate—Nausea—Temozolomide—skin cancer	0.000272	0.00142	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Docetaxel—skin cancer	0.000271	0.00142	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Fluorouracil—skin cancer	0.000268	0.0014	CcSEcCtD
Sodium lauryl sulfate—Rash—Fluorouracil—skin cancer	0.000266	0.00139	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Fluorouracil—skin cancer	0.000265	0.00139	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Docetaxel—skin cancer	0.000264	0.00138	CcSEcCtD
Sodium lauryl sulfate—Headache—Fluorouracil—skin cancer	0.000264	0.00138	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Docetaxel—skin cancer	0.000262	0.00137	CcSEcCtD
Sodium lauryl sulfate—Constipation—Docetaxel—skin cancer	0.00026	0.00136	CcSEcCtD
Sodium lauryl sulfate—Nausea—Fluorouracil—skin cancer	0.00025	0.00131	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Docetaxel—skin cancer	0.000249	0.0013	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Docetaxel—skin cancer	0.00024	0.00126	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Docetaxel—skin cancer	0.00024	0.00126	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Docetaxel—skin cancer	0.000224	0.00117	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Docetaxel—skin cancer	0.000218	0.00114	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Docetaxel—skin cancer	0.000215	0.00112	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Docetaxel—skin cancer	0.000208	0.00109	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Docetaxel—skin cancer	0.000201	0.00105	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Docetaxel—skin cancer	0.000193	0.00101	CcSEcCtD
Sodium lauryl sulfate—Rash—Docetaxel—skin cancer	0.000192	0.001	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Docetaxel—skin cancer	0.000192	0.001	CcSEcCtD
Sodium lauryl sulfate—Headache—Docetaxel—skin cancer	0.00019	0.000996	CcSEcCtD
Sodium lauryl sulfate—Nausea—Docetaxel—skin cancer	0.000181	0.000944	CcSEcCtD
